BONI, CAROLINA
 Distribuzione geografica
Continente #
NA - Nord America 2.341
AS - Asia 2.036
EU - Europa 1.367
SA - Sud America 366
AF - Africa 122
OC - Oceania 7
Totale 6.239
Nazione #
US - Stati Uniti d'America 2.263
SG - Singapore 877
CN - Cina 560
IT - Italia 387
BR - Brasile 304
IE - Irlanda 235
HK - Hong Kong 191
DE - Germania 177
SE - Svezia 168
VN - Vietnam 131
TR - Turchia 79
NL - Olanda 76
ZA - Sudafrica 76
FI - Finlandia 74
FR - Francia 68
CA - Canada 51
RU - Federazione Russa 42
IN - India 38
AR - Argentina 28
GB - Regno Unito 27
BD - Bangladesh 24
KR - Corea 24
MX - Messico 21
JP - Giappone 20
CI - Costa d'Avorio 18
AT - Austria 15
BE - Belgio 13
IQ - Iraq 13
PK - Pakistan 13
ID - Indonesia 12
UA - Ucraina 11
DK - Danimarca 10
LT - Lituania 10
EC - Ecuador 8
PL - Polonia 8
UZ - Uzbekistan 8
CO - Colombia 7
ES - Italia 7
MA - Marocco 7
PY - Paraguay 7
AU - Australia 6
CZ - Repubblica Ceca 6
KE - Kenya 6
CH - Svizzera 5
IR - Iran 5
RO - Romania 5
SA - Arabia Saudita 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
EG - Egitto 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
TN - Tunisia 3
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
LU - Lussemburgo 2
OM - Oman 2
PA - Panama 2
TZ - Tanzania 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TG - Togo 1
TO - Tonga 1
Totale 6.239
Città #
Singapore 448
Dallas 412
Ashburn 327
Santa Clara 257
Dublin 234
Hong Kong 189
Chandler 177
Parma 138
Beijing 135
Boardman 93
New York 88
Munich 85
Dearborn 79
Johannesburg 70
Shanghai 68
Izmir 65
Los Angeles 60
Ann Arbor 55
Ho Chi Minh City 47
Milan 45
Hanoi 39
Hefei 34
Nanjing 34
Princeton 34
São Paulo 32
Wilmington 31
Turku 28
Buffalo 26
Columbus 25
Moscow 23
Chicago 22
Toronto 21
Bologna 20
Frankfurt am Main 20
Abidjan 18
Shenyang 18
Tokyo 18
Rio de Janeiro 17
Houston 16
Nuremberg 16
Seoul 15
Grafing 14
Helsinki 14
Montreal 14
Nanchang 14
Brussels 13
Guangzhou 13
Hebei 13
The Dalles 13
Seattle 12
Bremen 11
Changsha 11
Phoenix 11
Denver 10
Düsseldorf 10
Jacksonville 10
Orem 10
Reggio Emilia 10
Bengaluru 9
Brooklyn 9
Jakarta 9
Limena 9
Rome 9
San Francisco 9
San Jose 9
Vienna 9
Baghdad 8
Curitiba 8
London 8
Montespertoli 8
Taastrup 8
Tianjin 8
Zhengzhou 8
Boston 7
Council Bluffs 7
Hangzhou 7
Jinan 7
Ottawa 7
Tashkent 7
Warsaw 7
Chennai 6
Mexico City 6
Norwalk 6
Rockville 6
Atlanta 5
Brasília 5
Da Nang 5
Focsani 5
Indianapolis 5
Istanbul 5
Jiaxing 5
Kunming 5
Nairobi 5
Ardea 4
Baku 4
Bangkok 4
Belo Horizonte 4
Bolzano 4
Bordeaux 4
Campinas 4
Totale 4.056
Nome #
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 257
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 240
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 230
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 203
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 169
Therapeutic potential of co-signaling receptor modulation in hepatitis B 150
Metabolic regulation of the HBV-specific T cell function 149
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 139
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 134
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 131
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 130
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 130
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 126
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 126
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 126
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 125
HBV immune-therapy: From molecular mechanisms to clinical applications 122
T cell regulation in HBV-related chronic liver disease 122
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 119
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 117
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 115
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 111
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 106
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 104
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 102
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 100
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 99
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 95
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 94
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 93
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 93
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 92
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 92
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 89
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 87
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 86
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 86
Comparative pathogenesis of HBV and HCV 85
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 85
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 82
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 82
Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology 79
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 78
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B 78
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 78
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy 76
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 75
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 74
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 73
The scientific basis of combination therapy for chronic hepatitis B functional cure 70
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections 70
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma 68
Immunopathogenesis of hepatitis C virus infection 68
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 67
Hepatitis B virus specific immune response: From antigen recognition to liver damage 65
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 65
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor 58
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection 51
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire 51
HBV antigens quantity: duration and effect on functional cure 50
Immunopathogenesis of hepatitis B 41
Totale 6.358
Categoria #
all - tutte 24.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 15 20 13 29 15 9 15
2021/2022198 8 4 3 26 20 21 11 13 13 4 11 64
2022/2023771 82 66 42 49 58 78 15 40 258 6 40 37
2023/2024548 27 49 27 52 31 119 56 28 25 35 37 62
2024/20251.912 63 91 102 127 200 234 110 127 232 136 163 327
2025/20262.275 348 568 390 296 470 203 0 0 0 0 0 0
Totale 6.358